Literature DB >> 29663568

Abnormal function of the UBA5 protein in a case of early developmental and epileptic encephalopathy with suppression-burst.

Cécile Mignon-Ravix1, Mathieu Milh1,2, Charlotte Sophia Kaiser3, Jens Daniel3, Florence Riccardi1,4, Pierre Cacciagli1,4, Majdi Nagara1, Tiffany Busa1,4, Eva Liebau3, Laurent Villard1,4.   

Abstract

Early myoclonic epilepsy (EME) or Aicardi syndrome is one of the most severe epileptic syndromes affecting neonates. We performed whole exome sequencing in a sporadic case affected by EME and his parents. In the proband, we identified a homozygous missense variant in the ubiquitin-like modifier activating enzyme 5 (UBA5) gene, encoding a protein involved in post-translational modifications. Functional analysis of the UBA5 variant protein reveals that it is almost completely unable to perform its trans-thiolation activity. Although recessive variants in UBA5 have recently been associated with epileptic encephalopathy, variants in this gene have never been reported to cause EME. Our results further demonstrate the importance of post-translational modifications such as the addition of an ubiquitin-fold modifier 1 (UFM1) to target proteins (ufmylation) for normal neuronal networks activity, and reveal that the dysfunction of the ubiquitous UBA5 protein is a cause of EME.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  Ohtahara syndrome; UBA5; early myoclonic epilepsy; encephalopathy

Mesh:

Substances:

Year:  2018        PMID: 29663568     DOI: 10.1002/humu.23534

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  8 in total

1.  A Genome-wide ER-phagy Screen Highlights Key Roles of Mitochondrial Metabolism and ER-Resident UFMylation.

Authors:  Jin Rui Liang; Emily Lingeman; Thao Luong; Saba Ahmed; Matthias Muhar; Truc Nguyen; James A Olzmann; Jacob E Corn
Journal:  Cell       Date:  2020-03-10       Impact factor: 41.582

2.  A description of novel variants and review of phenotypic spectrum in UBA5-related early epileptic encephalopathy.

Authors:  Lauren C Briere; Melissa A Walker; Frances A High; Cynthia Cooper; Cassandra A Rogers; Christine J Callahan; Ryosuke Ishimura; Yoshinobu Ichimura; Paul A Caruso; Nutan Sharma; Elly Brokamp; Mary E Koziura; Shekeeb S Mohammad; Russell C Dale; Lisa G Riley; John A Phillips; Masaaki Komatsu; David A Sweetser
Journal:  Cold Spring Harb Mol Case Stud       Date:  2021-06-11

3.  MRE11 UFMylation promotes ATM activation.

Authors:  Zhifeng Wang; Yamin Gong; Bin Peng; Ruifeng Shi; Dan Fan; Hongchang Zhao; Min Zhu; Haoxing Zhang; Zhenkun Lou; Jianwei Zhou; Wei-Guo Zhu; Yu-Sheng Cong; Xingzhi Xu
Journal:  Nucleic Acids Res       Date:  2019-05-07       Impact factor: 16.971

Review 4.  Decrypting UFMylation: How Proteins Are Modified with UFM1.

Authors:  Sayanika Banerjee; Manoj Kumar; Reuven Wiener
Journal:  Biomolecules       Date:  2020-10-14

Review 5.  Clearing Traffic Jams During Protein Translocation Across Membranes.

Authors:  Lihui Wang; Yihong Ye
Journal:  Front Cell Dev Biol       Date:  2021-01-08

Review 6.  Highly Specialized Ubiquitin-Like Modifications: Shedding Light into the UFM1 Enigma.

Authors:  Katharina F Witting; Monique P C Mulder
Journal:  Biomolecules       Date:  2021-02-10

Review 7.  UFMylation System: An Emerging Player in Tumorigenesis.

Authors:  Yu Jing; Ziming Mao; Fengling Chen
Journal:  Cancers (Basel)       Date:  2022-07-19       Impact factor: 6.575

8.  Indispensable role of the Ubiquitin-fold modifier 1-specific E3 ligase in maintaining intestinal homeostasis and controlling gut inflammation.

Authors:  Yafei Cai; Guangxun Zhu; Siyang Liu; Zezheng Pan; Michaela Quintero; Candace J Poole; Chunwan Lu; Huabin Zhu; Bianca Islam; Jan van Riggelen; Darren Browning; Kebin Liu; Richard Blumberg; Nagendra Singh; Honglin Li
Journal:  Cell Discov       Date:  2019-01-29       Impact factor: 10.849

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.